高等学校化学研究 ›› 2005, Vol. 21 ›› Issue (2): 183-186.
WANG Ying1, ZHAO Lu2, HE Cheng-yan3, XU Li-na1, YANG Hong1
WANG Ying1, ZHAO Lu2, HE Cheng-yan3, XU Li-na1, YANG Hong1
摘要: The G551D-CFTR mutation causing cystic fibrosis (CF) results from a missense mutation at codon 551(G551D) in the gene encoding of the cystic fibrosis transmembrane conductance regulator (CFTR).The G551D mutation in CFTR results in a reduced functional channel but G551D-CFTR is appropriately inserted in the apical membrane.In previous studies we discovered a class of high-affinity bicyclooctane (BCO)G551D-CFTR activators(G551DBCOs) with Kd down to 1μmol/L.In this study, we analyzed the pharmacological activation of G551D-CFTR by the G551DBCOs by means of short circuit current analysis and cell-based fluorescence quenching assay.The G551DBCOs-induced G551D-CFTR activation is cAMP-dependent and is less sensitive to thiazolidinone CFTR inhibitor CFTRinh-172.These data suggest that (1) the phosphorylation of G551D-CFTR by protein kinase A is required for the activation by G551DBCOs; (2) G551DBCOs and CFTRinh-172 may act at the same site on the G551D-CFTR molecule.